IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study. [electronic resource]
Producer: 20100302Description: 148-57 p. digitalISSN:- 1521-7035
- Adjuvants, Immunologic -- therapeutic use
- CD8-Positive T-Lymphocytes -- drug effects
- Cell Separation
- Cytokines -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Flow Cytometry
- Humans
- Immunologic Memory -- drug effects
- Interferon beta-1a
- Interferon-beta -- therapeutic use
- Longitudinal Studies
- Male
- Multiple Sclerosis, Relapsing-Remitting -- blood
- T-Lymphocyte Subsets -- drug effects
- T-Lymphocytes, Regulatory -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.